Research Paper Volume 16, Issue 6 pp 5676—5702
Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing
Figure 9. Somatic mutations of the KIRC. (A) The overall mutation profile of KIRC. (B) Interaction effect of gene mutation differentially in the two risk groups. (C) The mutation frequency of genes in the L-R group. (D) The mutation frequency of genes in the H-R group. (E) Differential expression levels of TMB between the two risk groups. (F) Differential expression levels of TIDE between the two risk groups. (G) The Kaplan-Meier curves for the low-TMB and high-TMB groups. (H) The Kaplan-Meier analysis curves for the patients stratified by MMGrisk and TMB.